Calyx Law LLP Announces New Partnership, Expands IP Leadership in Emerging Tech

Calyx Law LLP is proud to announce its formation as a partnership between Graham Pechenik and Frank L. Gerratana, marking a key milestone in the firm’s evolution.

Originally founded by Pechenik in 2016, Calyx Law has earned international recognition as a trailblazing intellectual property firm in the life sciences.

The new partnership represents both a continuation and an expansion, building on a nearly decade-long foundation while extending the firm’s reach into other transformative technologies including artificial intelligence (AI), decentralized science (DeSci), blockchain, robotics, neurotechnology, semiconductors, and fintech.

Frank Gerratana brings over 17 years of experience as a technology and IP attorney, specializing in patent law. He previously served as a partner in the Boston offices of global law firms. Gerratana’s deep technical background, including advanced degrees in computer science and electrical engineering, uniquely positions him to advise both innovative startups and Fortune 500 companies on complex patent strategies.

Named one of the “World’s Leading IP Strategists” by Intellectual Asset Management magazine, Gerratana’s insights into emerging technologies have appeared in Business Insider, The New York Times DealBook, and Financier Worldwide Magazine.

Graham Pechenik founded Calyx Law following experience at Quinn Emanuel in San Francisco and Kaye Scholer in New York, where he asserted and defended some of the nation’s most valuable patents across the agricultural, chemical, pharmaceutical, biotech, and technology sectors, working on landmark cases both at trial and on appeal, including before the U.S. Supreme Court.

In addition to his current client work, Pechenik serves on several academic, nonprofit, and corporate advisory boards. He is recognized as a leading voice in psychedelics IP law and policy, including through a collaboration with the UC Berkeley Center for the Science of Psychedelics and his role as editor-at-large at Psychedelic Alpha.

“I’m thrilled to form Calyx Law LLP with Frank,” said Graham Pechenik. “When I started the firm, the goal was to serve groundbreaking clients in fields traditional firms didn’t yet understand or support. We were the first to focus on cannabinoid-based drug development, and later the first to build a dedicated psychedelic therapeutics practice.

“With Frank, I’m excited to scale the same pioneering spirit into new areas where science, technology, and law converge to create new challenges and new opportunities.”

“Our partnership reflects our shared vision of a forward-looking practice built to support clients working at the leading edge of science and technology,” said Gerratana. “We bring the legal tools and strategic insight to match their ambition. Our clients are inventing the future, and we’re honored to help protect it.”

“Calyx Law’s success has always been shaped by a team of exceptional attorneys, patent agents, and professionals,” added Pechenik. “Frank and I look forward to expanding our dynamic team and we encourage like-minded people who share our passion for innovation and IP excellence to connect as we continue to grow.”

About Calyx Law LLP

Founded in 2016 and reestablished as a partnership in 2025, Calyx Law LLP provides strategic IP and legal counsel to visionary companies at the forefront of complex and emerging industries.

While a flower is budding, it is protected by a whorl of sepals that enclose it as it emerges and provide stability as it opens. This structure is the calyx. Like a calyx, we provide companies with the protection and support they need to go from pre-seed to full bloom.

For more information, visit https://calyx.law.

(Attorney advertising)

View source version on businesswire.com: https://www.businesswire.com/news/home/20250603592696/en/

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.